Search
Search
ASRS: 2024
Christina Y. Weng, MD, MBA
Show Description +
Dr. Weng shares the pooled safety analysis of 8 mg aflibercept (Eylea HD, Regeneron) for up to 96 weeks in the CANDELA, PHOTON, and PULSAR trials.
Posted: 8/01/2024
Christina Y. Weng, MD, MBA
Dr. Weng shares the pooled safety analysis of 8 mg aflibercept (Eylea HD, Regeneron) for up to 96 weeks in the CANDELA, PHOTON, and PULSAR trials.
Posted: 8/01/2024
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2024.
_1722955835.png?auto=compress,format&w=180)
_1722955753.png?auto=compress,format&w=180)
_1722955632.png?auto=compress,format&w=180)
_1722955835.png?auto=compress,format&w=504)
_1722955753.png?auto=compress,format&w=504)
_1722955632.png?auto=compress,format&w=504)
Please log in to leave a comment.